Distinct Secondary Structures of the Leucine-Rich Repeat Proteoglycans Decorin and Biglycan: Glycosylation-Dependent Conformational Stability by Krishnan, Priya et al.
_._.B._._ _,_._,_ ,-_ _'_"
Distinct Secondary Structures of the Leucine-Rich Repeat Proteoglycans Decorin and
Biglycan: glycosylation-dependent conformational stability //j__._i/
Pfiya Krishnan _'_[, Anne M. Hocking '_'q[, I. Martin Scholtz t , C. Nick Pace t,
Kimberly K. Holik _[, and David J. McQuillan _' §
_Center for Extracellular Matrix Biology, Institute of Biosciences and Technology, 2121 W.
Holcombe Blvd., Houston TX 77030; tDepartment of Medical Biochemistry & Genetics, College
Station TX 77843-1114, Texas A&M University System Health Science Center
Running title: Structure of decorin and biglycan
Tel. (713) 677-7575
Fax. (713) 677-7576
Email: dmcquill @ibt.tamu.edu
This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and
Skin Diseases (AR42826), and from NASA/Texas Medical Center (NCC9-36).
'eThese authors contributed equally to this work
§To whom correspondence should be addressed
https://ntrs.nasa.gov/search.jsp?R=19990024880 2020-06-15T22:41:19+00:00Z
Summary
Biglycan and decorin, closely related small leucine-rich repeat proteoglycans, have been
overexpressed in eukaryotic ceils and two major glycoforms isolated under native conditions: a
proteoglycan substituted with glycosaminoglycan chains; and a core protein form secreted devoid
of glycosaminoglycans (A.M. Hocking, R.A. Strugnell, P. Ramamurthy, D.J. MeQuillan, J.
BioL Chem. 271: 19571-19577, 1996; P. Ramamurthy, A.M. Hocking, D.J. MeQuillan, J.
Biol. Chem. 271: 19578-19584, 1996). A comparative biophysical study of these glycoforms has
revealed that the overall secondary structures of biglycan and decorin are different. Far-l.W CD
spectroscopy of decorin and biglycan proteoglycans indicates that, although they are
predominantly _sheet, biglycan has a significantly higher content of _-helical structure. Decorin
proteoglycan and core protein are very similar, whereas the biglycan core protein exhibits closer
similarity to the decorin glycoforms than to the biglycan proteoglycan form. However, enzymatic
removal Of the chondroitin sulfate chains fi:om biglycan proteoglycan does not induce a shift to the
core prgtein structure, suggesting that the final form is influenced by polysaccharide addition only
during biosynthesis. Fluorescence emission spectroscopy demonstrated that the single tryptophan
residue, which is at a conserved position at the C-terminal domain of both biglycan and decorin, is
found in similar microenvironments. This indicates that, at least in this specific domain, the
different glycoforms do exhibit apparent conservation of structure. Exposure of decorin and
biglycan to 10 M urea resulted in an increase in fluorescent intensity, which indicates that the
emission from tryptophan in the native state is quenchedl Comparison of urea-induced protein
unfolding curves provided further evidence that decorin and biglycan assume different structures in
solution. Decorin proteoglycan and core protein unfold in a manner similar to a classic two-state
model, in which there is a steep transition to an unfolded state between 1-2 M urea. The biglycan
core protein also shows a similar steep transition. However, biglycan proteoglycan shows a broad
unfolding transition between 1-6 M urea, probably indicating the presence of stable unfolding
intermediates.
INTRODUCTION
Decorin and biglycan are small proteoglycans comprising chemically similar core proteins
substituted at the N-terminal end with one or two chondroitin/dermatan sulfate chains,
respectively. Despite the presumed structural similarity between biglycan and decorin (1), they
have distinct patterns of temporal and spatial expression suggesting different functions. They are
members of a family of glycoproteins grouped together on the basis of their presence in the
extracellular matrix, and by virtue of a leucine-rich motif that dominates the core protein (for
review, see (2)). Most of the members of this family exist in tissues as proteoglycans and have
been labeled the small leucine-rich repeat proteoglycans (SLRPsl).
The protein core of decorin (Fig. la) and biglycan (Fig. lb) can be divided into distinct domains,
based on amino acid sequence and specific post-translational modifications. A signal sequence
targets the nascent polypeptide to the secretory route; a short propeptide of highly charged
amino acids undergoes differential tissue- and cell- specific cleavage; an N-terminal
glycosaminoglycan attachment region containing one (decorin) or two (biglycan) $er-Gly di-
peptide consensus sequences; a leucine-rich repeat (LRK) domain that represents more than two
thirds of the core protein is flanked by highly conserved disulfide bonded eysteine clusters; and a
short C-terminal domain. The core protein of decorin has three consensus sites for N-linked
oligosaccharides; two of these sites are conserved in biglycan.
The post-translational modifications of decorin and biglycan are complex and variable, wherein
differentially glyeosylated forms of these molecules have been isolated from tissues and cells.
Decorin core protein devoid of a glycosaminoglycan chain has been isolated (3,4), although it is
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yet to be demonstratedwhetherthis is due to post-secretorycleavageof the GAG attachment
domain,or synthesisandsecretionof coreprotein that bypassesthe GAG synthetic machinery.
There is evidencethat membersof the SLRP family may be "part-time" proteoglycans.
Overexpressionof decorinandbiglycanyields significantamountsof secretedcoreprotein devoid
of glycosaminoglycanchains(5,6),the proportion of which appearsto be cell type-dependent
andrelatedto theendogenousactivity ofxylosyltransferase2(the enzymethat catalyzesthe first
sugartransferreactioninitiating chondroitinsulfatepolymerizationon a coreprotein substrate).
The decorincoreprotein is differentially substitutedwith N-linked oligosaccharides (5,7,8) with
two and three sites utilized.
The leucine-rich repeat (LRR) is a structural motif first identified by Patthy (9) and subsequently
refined by Kobe and Deisenhofer (10), that is usually present in tandem array and has been
described in an increasing number of proteins, giving rise to a LRK superfamily. It is likely that
the conserved residues of each LRK motif define the secondary structure, while the intervening
residues determine specificity of interaction with ligands. In 1993, Kobe and Deisenhofer solved
the crystal structure of ribonuclease inhibitor (11), a LRR protein that consists of fifteen repeats.
This remains the only report of the detailed structure of a LRK protein and may provide a
prototype for all LR__Kproteins. Each LRK consists of a 13-sheet parallel to an a-helix forming a
hairpin structure which is aligned parallel to a common axis resulting in a non-globular horseshoe
shaped protein. Binding of the ligand to the concave face (i.e. 13-strands) results in a
conformational change of the entire structure and increases the available surface area for binding.
4
The LRR domainof the SLRPfamily membersis unique within the superfamily in that it is
flankedby cysteineclusters;at the N-terminalendof the LRR domainthere are four similarly
spacedcysteineresiduesin a twenty aminoacidstretch which are involvedin disulfide bonds;
andat theCOOH-terminalendtherearetwo cysteineresiduesalsobelievedto form an intrachain
disulfidebond. The24aminoacidLRR consensusfor membersof the SLRPfamily is x-x-I/V/L-
x-x-x-x-F/P/L-x-x-I_-x-x-L-x-x-L/I-x-L-x-x-N-x-I/L,where x is any aminoacid,and in the case
wheremore thanoneaminoacidis noted,thefirst occursmostoften(2).
Attemptshavebeenmadeto predictthestructureof decorin (and related molecules) based on the
crystal structure of ribonuclease inhibitor. Computer modeling, constrained by parameters
established by the structure of ribonuclease inhibitor, have suggested that the decorin core protein
forms an arch-shaped protein with the glycosaminoglycan chain and N-linked oligosaccharides
situated on the same side of the molecule (1). High magnification rotary shadowing electron
micrographs of scleral decorin reveal a similarly "horseshoe-shaped" molecule (12) consistent
with the computer modeling prediction. However, the ribonuclease inhibitor is composed
entirely of LRRs, whereas the N- and C- termini of SLRPs have extended non-LRR containing
domains. The inhibitor lacks cysteine clusters flanking the LRR domain which, through
intramolecular disulfide bond formation (13), might provide points of stabilization at either end
of the LRR domain. The length of the decorin repeat motif is 24 residues, which is shorter than
for ribonuclease inhibitor and may result in a restricted 13-sheet. Furthermore, the extensive
glycosylation of SLRPs may influence the folding of the LRR domain.
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In the current study, our data indicatethat recombinanthuman decorin and biglycan have
different secondarystructuresin solutionandmarkeddifferencesin conformationalstability, as
assessed by circular dichroism and fluorescent spectroscopy, which is inconsistent with the
utility of modeling based solely on the structure of ribonuclease inhibitor. Furthermore, we
provide evidence that both the conformation and stability of these molecules is variably
influenced by whether they are synthesized with or without a glycosaminogIycan chain, whereas
removal of polysaccharides after secretion has no appreciable influence on conformation or
stability.
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EXPERIMENTAL PROCEDUJRES
Materials - Ultrapure urea was obtained from Ambion Inc. (Austin, TX). Ultrafree-15 centrifugal
filtration devices were from Milh'pore Corp. (Bedford, MA). All other materials were obtained as
previously described (6).
Protein purification - Recombinant decorin and biglycan glycoforms were expressed and purified
using the vaccinia virus/T7 bacteriophage expression system, as previously described (5,6). Briefly,
recombinant proteins were purified on a column of iminodiacetic acid immobilized on Sepharose
613. Proteoglycan and core protein forms were resolved and eluted by a linear gradient of imidazole
in column buffer (0.5 M NaC1, 20 mM Tris-HC1, pH 8.0). Pooled fractions were dialyzed against
phosphate-buffered saline (PBS) pH 7.4 and concentrated on Ultrafree-15 centrifugal falter devices.
Protein concentrations were determined by the molar extinction coefficient (14).
Stock solutions - Urea stock solutions (10 M) in a buffer of 50 mM NaH2PO,JI_HPO4, pH 7.0
(15), were prepared daily for each experiment and filtered (0.22-1ma pore) prior to use. The urea
concentration of each stock solution was calculated by weight and by refractive index (15). The
buffer solution without urea is referred to as "phosphate buffer".
Circular dichroism spectroscopy - CD spectra of protein Samples were recorded on a Jasco 720
spetropolarimeter using a 2 mm path-length quartz cell at room temperature at a concentration of 10
in phosphate buffer. The recorded spectra (190-250 nm) were the average of i0 scans and
were corrected to background (phosphate buffer alone). Sample cuvettes were sealed with a Teflon
stopper so that no evaporation occurred.
(0) by the following equation:
0 (deg.cm x.dmol -_) --
The CD signal (mdeg) was converted to molar eUipticity
m deg× 0.1
molarity( M) × pathlength( cm) × amino acid residues
t
Fluorescence emission spectroscopy - Fluorescence emission was measured using a FluoroMax2
spectrofluorometer; the pathlength of the cuvette was 1 mm and the signal averaged for 50 seconds.
The excitation wavelength for tryptophan emission was 296 nm in all experiments. Emission scans
were collected from 300-500 nm.
Equilibrium unfolding curves- Equilibrium unfolding experiments were done as previously
described (15). Briefly, stock solutions were prepared in phosphate buffer to be 10 times the
desired f'mal protein concentration. Phosphate buffer, urea from the 10 M stock solution, and 100
IA of stock protein solution to give a final volume of 1 ml were mixed; this yielded final urea
concentrations of 0-8 M and a final protein concentration of 10 _M. Protein samples were gently
mixed and equilibrated for 18 h at 25°C. Unfolding was monitored using circular dichroism
spectroscopy and fluorescence emission spectroscopy. The CD signal was determined at 220 nm
for the proteoglycan and core protein forms of biglycan and decorin.
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RESULTS AND DISCUSSION
Recombinant biglycan and decorin were expressed in the vacciniaO'7 bacteriophage system (5,6).
Both biglycan and decorin were synthesized as two glycoforms: a proteoglycan form, and a core
protein form that was secreted devoid of glycosamJ.uoglycan chains.
Circular dichroism spectroscopy- Far-UV CD spectra were measured for native recombinant
biglycan and decorin glycoforms (Fig. 2). Biglycan proteoglycan had spectra with minima at 220
nm (Fig. 2a, solid circles); the CD spectra of decorin proteoglycan was different, with a minima at
218 nm and a broader curve (Fig. 2c, solid circles). Several deconvolution computer programs were
used to facilitate an objective comparative analysis of the CD spectra, including SELCON (16),
VARSELEC (17,18), CCA (19), and Contin (20) using file conversion software (SOFTSECa_:
File Conversion for Windows obtained from Softwood Company). The estimated contribution
of different structural motifs (i.e. S-sheet, _tum, a-helix, random coil) varied between different
deconvolution programs (data not shown), but it was nevertheless consistently determined that
biglycan and decorin assumed different structures in solution. For instance, the method of
Sreerama and Woody (16) predicted that the secondary structure of biglycan to be 30% a-hell.x,
14% _sheet, 15% 13-tum and 46% random coil, whereas decorin comprised 8% a-helix, 44% 13-
sheet, 14% [3-tum and 33% random coil.
After equilibration of recombinant biglycan and decorin in 10 M urea for 16 hours, samples were
analyzed by CD spectroscopy (Fig. 2, open circles). The CD spectra for both biglycan (Fig. 2a,
open circles) and decorin (Fig. 2c, open circles) in 10 M urea reflected a loss of CD signal typical
of an absence of secondary structure.
CD spectroscopy was also used to examine the secondary structure of the core protein glycoforms
of biglycan and decorin (Fig. 2). The CD spectra for the biglycan core protein in phosphate buffer
hadaminimaat215am(Fig.2b,solidcircles), with a significantly broader curve than seen for the
proteoglycan form (Fig. 2a). Computer deconvolution analysis predicted that the secondary
structure of biglycan core protein was significantly different to the proteoglycan form (13% a-helix,
36% B-sheet, 19% B-turn and 37% random coil (16)). Thus the biglycan core protein, synthesized
devoid of glycosaminoglycan chains, had a secondary structure that is different to the proteoglycan
form. The effect of chondroitin sulfate chain addition on the secondary structure of biglycan and
decorin core proteins was assessed by digestion with chondroitinase ABC (to remove the
glycosaminoglycan chains). There was no detectable difference between the spectra generated from
undigested and digested proteoglycans. Glycosaminoglycan chains, at 10-fold higher concentration
than in samples analyzed in Fig. 2, did not contribute to the CD spectra (data not shown).
Therefore, removal of the glycosaminoglycan chains from secreted proteoglycan does not
significantly influence secondary structure.
Comparison of the CD spectra of decorin core protein (Fig. 2d, solid circles) with the spectra of
decorin proteoglycan (Fig. 2b, solid circles) showed essentially identical curves with the minima of
both glycoforms at 218 nm. The CD scans clearly show that decorin and biglycan have distinct
secondary structures. Furthermore, biglycan synthesized and secreted devoid of chondroitha sulfate
chains assumes a different structure to biglycan substituted with chondroitin sulfate. However,
removal of the bulk of the chondroitin sulfate mass from biglycan after purification had no
measurable influence on the structure. Biglycan appears to have more a-helical content in its
secondary structure relative to biglycan core and decorin glycoforms, which are primarily 13-sheet in
structure. Decorin, on the other hand, appears to form the same structure in solution irrespective of
substitution with chondroitin sulfate.
Fluorescence spectroscopy - The mature core protein of biglycan and decorin both have a single
tryptophan residue situated between the two conserved cysteine residues at the C-terminal end of
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the coreprotein(Fig. 3a). Peptidesequencingof bovinebiglycanhasshownthatthesecysteines
form anintramoleculardisulfidebond(13). Comparisonof the aminoacid sequencein this region
revealsthat biglycananddecorinshare65%aminoacididentity. Fluorescencespectroscopywas
usedto analyzetheenvironmentof this tryptophanin nativeand denaturedbiglycan and decorin.
Thefluorescentintensityfor all fourglycoformsincreasedin thepresenceof 10M urea(Fig. 3b-e,
closedcircles)relativeto the intensityin phosphatebuffer (Fig. 3b-e,solid circles). Thesedata
indicatethat theemissionfrom the tryptophanin the nativeglycoforms is quenched. Biglycan
proteoglycanin PBS hada maximumemissionwavelengthof 342 nm (Fig. 2b,opencircles)and
afterdenaturationthepeakemissionwavelengthwasshifted to 352 nm (Fig. 2b, closedcircles).
The maximumemissionwavelengthof decorinproteoglycanin PBS was 345 nm [Fig. 2d, solid
circles);in 10M urea,the emissionwavelengthshiftedto 354 nm [Fig. 2d,opencircles). These
resultssuggestthatthetryptophanin nativebiglycananddecorinis partiallyburied; in denatured
biglycananddecorin,thetryptophanis exposedto apolarenvironment.
The magnitudeof the peak emissionwavelength' shift for the native and denatured core protein
forms of biglycan [Fig. 3c) was similar to that observed for the proteoglycan form (Fig. 3b). The
intrinsic fluorescence spectra for biglycan core protein revealed that the native protein had an
emission maxima at 341 nm (Fig. 3c, solid circles) which shifted to 353 nm for the denatured
protein (Fig. 3d, open circles). Therefore, it appears that the tryptophan is in a similar environment
in both glycoforms of biglycan. The spectra for native decorin core protein had a peak emission
wavelength maxima of 350 nm [Fig. 3e, solid circles). The maxima for the fluorescence spectra of
decorin core protein in 10 M urea was 355 nm [Fig. 3e, open circles). The peak emission
wavelength for decorin is different between core protein (350 nm) and proteoglycan (345 nm)
which indicates that the microenvironment of the tryptophan in these two glycoforms may be
different. The decofin core protein (Fig. 3e) is more solvent exposed in the native state relative to
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the decorinproteoglycan(Fig. 3d). However,takentogetherthesesubtledifferencessuggestthat
theC-terminaldomainis structuredsimilarly amongall fourglycoforms.
Urea denaturation curves - To further characterize structural differences between biglycan and
decorin, the conformational stability was investigated. Urea denaturation curves were determined
for each glycoform of biglycan and decorin. The CD spectra (shown in Fig. 2) revealed the
maximal CD signal difference between native and denatured proteoglycan was at 220 nm, and this
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wavelength was used to monitor changes in the CD signal as unfolding occurred. The denaturation
curves generated for the proteogIycan forms of biglycan and decorin are complex (Fig. 4), but
highly reproducible, and were not amenable to curve fitting algorithms. The denaturation curve for
biglycan proteoglycan indicates the protein is very susceptible to urea denaturation based on the
limited pre-transition baseline from 0-0.5 M urea (Fig. 4a). However, the transition from the folded
to unfolded state occurs gradually from 1-6 M urea, and it is not clear where the post-transition
baseline begins. The unfolding of biglycan proteoglycan probably proceeds through stable
intermediates reflecting sequential disruption of domains. Unfolding of decorin proteoglycan
foUows a simpler, possibly two-state, mechanism (Fig. 4b), with a pre-transition baseline from 0-1.0
M urea, a sharp transition between 1.0-2.0 M urea, and an apparent post-transition baseline with
increasing urea concentration.
The urea-induced unfolding of the core protein glycoforms of biglycan and decorin was also
examined. Biglycan core protein (Fig. 4c) had a pre-transition between 0-1.5 M urea, a sharp
transition between 1.5-2.5 M, followed by a slowly increasing post-transition above 3.5 M urea.
The denaturation curve for decorin core protein was similar to both the biglycan core protein and
the decorin proteoglycan glycoforms, with a pre-transition region at 0-1.0 M, a transition from 1.0-
2.0 M urea, and a similar post-transitional baseline at higher urea concentrations (Fig. 3d).
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Reversibility of unfolding - Reversibility of unfolding is an important parameter when defining
corrformational stability. All four glycoforms were equilibrated in 10 M urea and then diluted to a
urea concentration of 1.0 M urea, at a final concentration of 10 12¢I. This preparation was
compared with glycoforms (10 _M) that had been equilibrated directly in 1 M urea or 10 M urea.
The effect on secondary structure was examined by far-UV CD spectroscopy (Fig. 5). All of the
refolding profiles (Fig. 5, triangles) demonstrate that none of the glycoforms were able to refold to
their original conformation after exposure to 10 M. The biglycan proteoglycan in PBS (Fig. 2a,
solid circles) and 1.0 M urea (Fig. 4a, solid circles) had similar CD profiles, with a minima of 215
nm. After exposure to 10 M urea and subsequent dilution to 1 M urea, the minima shifted to 213
nm and the curve was significantly broader (Fig. 4a, triangles). Decorin proteoglycan equilibrated
in 1 M urea overnight had a similar spectra to native proteoglycan (Fig. 4c, closed circles). When
the urea concentration was diluted back to 1 M urea, the secondary structure was reproducibly
different to the CD spectra of the native proteoglycan, exhibiting a minima at 214 nm and a
significantly broader curve (Fig. 4c, triangles). The biglycan core protein in PBS and in 1 M urea
(Fig. 4b, squares) had a minima ~ 218 nm, which was shifted to 209 nm in the refolded spectra
(Figl 4b, triangles). The spectra for decorin core protein in 1.0 M urea (Fig. 4d, circles) had a
minima at 216 rim, and the refolded protein (Fig. 4d, triangles) had a spectra with a minima at 214
nm. These spectra clearly demonstrate these refolded glycoforms do not appear to assume the
same secondary structure as in the native state, under the conditions used. Indeed, it is possible that
the refolded form has a molten globule-like structure that may regain a secondary structure but does
not resemble the native folded protein (21).
In summary, comparison of the biophysical properties of biglycan and decorin indicates that these
small leucine-rich repeat proteoglycans have different overaU secondary structures, as assessed by
circular dichroism spectroscopy. However, fluorescence spectroscopy indicates that the conserved
tryptophan in the C-terminal di-sulfide bonded domain is in a similar environment for both biglycan
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and decorin. A qualitativeanalysisof conformationalstabilityrevealedthepossibility of multiple
transitions during urea-inducedunfolding of biglycan proteoglycan,in contrastbiglycan core
protein and the decorin glycoforms appear to follow a two-state unfolding mechanism.
GlycosylationalsohaddifferentialeffectsonthestructureandStabilityof biglycan,but not decofin.
Thecoreproteinform of biglycanis morestablethantheproteoglycan,andthey appearto assume
different structuresin solution. This is in contrastto the decorincoreprotein,which assumesa
similarconformationindependentof substitutionwith aglycosaminoglycanchain.
Glycosaminoglycansare long extendedpolymers of repeating disaccharideunits. It is not
unreasonable to speculate that these large polysaccharides can influence the structural conformation
or stability of a protein. In this study, the chondroitin sulfate chains of biglycan may have a critical
role in stabilizing the secondary structure of the whole protein. Significant differences in the CD
spectra of the native biglycan proteoglycan and core protein provides evidence that the presence of
glycosaminoglycan chains can alter structure. It is unclear how the glycosaminoglycan affects the
secondary structure, but it should be noted that this is not a general role in proteoglycans as the
glycosaminoglycan chains of decorin had no detectable effect on structure or conform ational
stability. This observation once again confh-ms that biglycan and decorin have different folded
conformations. Furthermore, this study clearly indicates that there are inherent flaws in applying
generalizations from the structure of one member of the LRR superfamily to other distantly related
proteins. It further emphasizes the need for the structure of one or more members of the SLRP
family to be solved, and this will impact significantly on the biology of these molecules with respect
to their role in collagen fibrillogenesis (22,23), modulation of TGF-B activity (24-28), and
interaction with cell surface receptors (29-31).
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FOOTNOTES
1. Abbreviations used: SLRP, small leucine-rich repeat proteoglycans; LRR, leucine-rich repeat;
GAG, glycosaminoglycan; PBS, phosphate buffered saline; CD, circular dichroism.
2. Hocking, A.M., Seo, N-S., and McQuillan, D.I., manuscript in preparation
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FIGURE LEGENDS
Figure 1. Schematic representation of (a) decorin and (b) biglycan, indicating major domains,
including: signal sequence (sig), propeptide (pro), glycosaminoglycan attachment (GAG), putative
di-sulfide bonds (boxed S), ten leucine-fich repeats (numbered boxes), and N-linked
oligosaccharide attachment sites.
Figure 2. Far-UV CD spectra of (a) biglycan proteoglycan, (b) biglycan core protein, (c) decorin
proteoglycan, and (d) decorin core protein, in phosphate buffer (0) and after equilibration in 10 M
urea (O). The vertical dashed line is in an identical position in all panels and is provided to assist in
curve comparison.
Figure 3. Fluorescence emission spectra of recombinant glycoforms. (a) Amino acid sequence
spanning the C-terminal di-sulfide bonded cysteine domain of decorin (upper sequence) and
biglycan (lower sequence). Conserved residues are indicated by vertical lines, and the conserved
tryptophan (W) is boxed. Fluorescence emission spectra are shown for CO) biglycan proteoglycan,
(c) biglycan core prote_, (d) decorin proteoglycan, and (e) decorin core protein, in phosphate
buffer (0) and after equilibration in 10 M urea (O). The vertical dashed line is in an identical
position in all panels and is provided to assist in curve comparison.
Figure 4. Urea induced unfolding of (a) biglycan proteoglycan, Co) biglycan core protein, (e)
decorin proteoglycan, and (d) decorin core protein. Glycoproteins (10 gM) were equilibrated
overnight in increasing concentrations of urea, and unfolding monitored by far-UV circular
dichroism spectroscopy.
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Figure 5. Refolding of (a) biglycan proteoglycan, (b) biglycan core protein, (c) decorin
proteoglycan, and (d) decorin core protein, after urea denaturation. Far-U'V CD spectra of
glycoprotein (10 pM3 equilibrated overnight in: i M urea (0); 10 M urea (X); and 10 M urea for 6
h then diluted into 1 M urea and equilibrated for 12 h (_,).
20
Fig. 1 Krishnan et aI.
sig pro
GAG chain
N-linked oligosaccharide
leucine-rich repeats
C_cD
Fig. 2, Krishnan et al.
Far UV CD-spectra
2
v,...4
-2
-4
-6
2
<:D -2
-4
-6
a biglycan ] biglycan b
,.... proteoglycan _ core protein
/ " L,',."" "
i-. -- - .._-_ .................. ,,_... j ...... %- ...........
F- • "--"- .." I- "... .."
" .-" ".. ....."f / , L
r • ," [
[ ". ! ::-PBS [ [
| "T" o 10 M urea !
| I ! 1 I I I I I I
l c _:oCteo_lycan l ;". derCe°protein d
_'" !. ' "
_._.. l ...................... ...It .r.. t ..................... ...1
/ ":".... _.,,r%, . ,. __.-._"-- I
• ". _.'"--."" _ " . " .*"*"---." I
• -.,...." ... _ .: . .,." ..."
" o; ", °° "
• • o"
• 00 • •
• 00 • QO
• I. • I.
"..,_." ".._."
!
I ! ....I I I I I I
210 220 230 240 210 220 230 240
Wavelength (nm)
Fig. 3, Krishnan et al.
a C-terminal cysteine domain
321CPMGFGVKRAYYNGI SLFNNPVPY _ EVQ PATFRC 354
313111 I II I III III I1111 il 1111346
CPPGHNTKKASYSGVSLFSNPVQY IWI EIQPSTFRC
Fluorescence emission spectra
61 _ biglycan C biglycanj,,\  or proto 
2 _/ _ urea
l I I ! !i I
6-d decorin . e de=in
,_ proteoglycan core protein
4
2
! 1
350 400 450 350 400 450
Wavelength (nm)
Fig. 4, Krishnan et al.
-10
-15
-20
,_ -25
-15
-2o
-25
Protein unfolding with urea
a
)o °
C
00
IoelO
• O
oo •
i
I
2
biglycan
proteoglycan
I I I
logo o•°
•0oo
I
I
4
"" " b
I
o 0 o •
I
.d
i• I
decorin
proteoglycan
Io
Ol• Og
1o
O 0
• O• 0
ooOOo 0°0
• •i
biglycan
core protein
I ..!
gO
• OOO • •
decorin
core protein
I I I I I
6 8 2 4 6
Urea concentration (M)
-4
-6
-8
-10
-12
-14
-16
-20
-30
-40
-50
ra_
r,.)
Fig. 5 Krishnan et al.
Refolding after urea denaturation
biglycan b biglycan
6 a prote0glycan _ core protein
4 l e 1 Murea I
2 " [x 10 M ttrea " i xXx
• X Ja lOMuma---_lMuma I x
0 _,-. -,-. _ _ ...... __,_ -,,- ---" - ---_
| _XxXx ._***_W_ L_ x _ ...,,,_a_- IL- " __'-_.'_" [5".._ ._'_7._'- I
,,'7 t
,._ / • • x ._oe- J _#'"-- I
6L "2. A-" L _ I[ I I
L , , , n I u n u n I
eq_t) 6 . dreoCter_glycan . . tein
X
0 -. ........ -" ,, ._._-_ .... " - ._!- _ - - - - - -_..._'_ ,_. ......./" • ,, ._,.,__ I,_ , "- __..-' I
t-_ _ ; ",,/- / - I • " " .,-".-" i
-4F ", ; " " ,,," " I- ' " ./.." I
/ ",, ... J I ,,.- f." I
" ! I ! !
210 220 230 240 210 220 230 240
Wavelength (nm)
